CSIMarket Company Name, Ticker, Suppliers, else..
 
Iridex Corp  (NASDAQ: IRIX)

Iridex Corp

Officers & Directors


Robert Grove
Director

David I. Bruce
President and Chief Executive Officer

Nandini Devi
Director

Fuad Ahmad
Interim Chief Financial Officer

Beverly A. Huss
Director

Kenneth E. Ludlum
Director

Scott Shuda
Chairperson of the Board ,

Iridex Corp currently has 93 employees.

  News about Iridex Corp Key Personnel

“Iridex’s Fight for Survival: Will Innovation or Investment Steer the Company Back to Health”

In a landscape marked by rapid technological advancements and fierce competition, Iridex Corporation (NASDAQ: IRIX), a prominent player in the medical device industry, has found itself at a crossroads. Founded with the vision of revolutionizing the treatment of glaucoma and retinal diseases through innovative laser-based medical systems and delivery devices, the company is now grappling with stark financial realities. Preliminary Financial ResultsAs of April 14, 2025, Iridex disclosed preliminary unaudited operational and financial results for the first quarter ending March 29, 2025. These results paint a concerning picture: a cumulative net loss of $9 million during the last twelve months leading up to the ...

Cash Infusion Amid Crisis: Can Iridex Innovate Its Way Back to Financial Health,

ArticleIn a bold move that underscores both the potential and precarious state of Iridex Corporation (NASDAQ: IRIX), the Mountain View-based company recently closed a strategic investment deal worth $10 million, backed by Novel Inspiration International Co. Ltd. This investment raises questions about Iridex’s financial sustainability and its ability to capitalize on groundbreaking innovation in the competitive healthcare market.Founded in 2020, Novel Inspiration is led by William Moore, a familiar face in Iridex’s boardroom, having served both as a board member and the company’s Chief Executive Officer. This connection raises eyebrows—was this deal a lifeline or merely a stopgap measure to stave off...

“Iridexs Medical Breakthroughs: A Silver Lining in the Storm of Stock Market Struggles”,

Iridex Faces Stock Market Turbulence Amid Groundbreaking Innovation in Glaucoma TreatmentBy CSI Market MOUNTAIN VIEW, Calif. — In the face of considerable stock price volatility, Iridex Corporation (NASDAQ: IRIX), a recognized leader in laser-based medical systems for glaucoma and retinal diseases, has publicly addressed its recent financial struggles while simultaneously spotlighting its innovations in glaucoma treatment. This dual narrative presents a company at a crossroads, where groundbreaking advances in medical technology contend with substantial financial challenges.According to the most recent financial data, Iridex recorded a substantial cumulative net loss of $11 million for the 12 months e...






IRIX Management Effectiveness IRIX Revenue per Employee IRIX Income per Employee


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.